TY  - JOUR
AU  - Ovejero Paredes, Karina
AU  - Giovanni Bisbano
AU  - Inge Flier
AU  - Alejandro Gonzalez-Simon
AU  - Marciello, Marzia
AU  - Sabrina Oliveira
AU  - Marco Zupi
AU  - Davide Rubes
AU  - Fatima Ayash
AU  - Filippo Doria
AU  - Valentina Pirota
AU  - Marco Terreni
AU  - Massimo Serra
AU  - Filice, Marco
PY  - 2025
DO  - 10.1016/j.ejps.2025.107216
UR  - https://hdl.handle.net/20.500.14352/137041
T2  - European Journal of Pharmaceutical Sciences
AB  - Triple negative breast cancer (TNBC) represents one of the most aggressive types of cancer, with a difficult treatment leading to poor prognosis of the disease. Herein we report the synthesis of a custom-made cyclic RGD peptide (cRGD), and its use in...
LA  - eng
M2  - 107216
PB  - Elsevier
KW  - Liposome
KW  - Nanomedicine
KW  - cRGD
KW  - Integrins
KW  - Anticancer
KW  - Microfluidic
KW  - Triple-negative breast cancer
KW  - Drug delivery
KW  - Theranosis
KW  - Precision medicine
KW  - Nanobiotechnology
KW  - Cell spheroids
KW  - 3D in vitro models
TI  - Microfluidic-assisted synthesis of integrin-targeting cRGD liposomes as a scalable strategy for theranostic applications in triple-negative breast cancer
TY  - journal article
ER  -